AKT1 and pancreatic neoplasm: In a study involving mass spectrometry analysis of the secretome of MYB-regulated and controlled pancreatic cancer cell lines, it was found that knockdown of c-MYB can downregulate the signaling pathways associated with glucose metabolism, the PI3K/AKT signaling pathway and oxidative stress response, among other genes (35).